SCHEMBL25828286

SCHEMBL25828286

Cc1ccc2c(c1C)CC(=O)N2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.40
THRB P10828 1/20 0.39
TRIM24 O15164 1/20 0.37
OPRK1 P41145 1/20 0.36
PDE4D Q08499 1/20 0.36
BMPR1B O00238 3/20 0.35
BMPR1A P36894 3/20 0.35
ACVRL1 P37023 3/20 0.35
ACVR1 Q04771 3/20 0.35
TGFBR1 P36897 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34
MAPT P10636 1/20 0.34
BRPF1 P55201 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16132463 0.83 BRD4 (0.44) PKMHSD17B10TP53HPGDBRD4
SCHEMBL760693 0.81 CCNB2 (0.37) PKMTHRBTRIM24OPRK1PDE4D
SCHEMBL21603583 0.81 PKM (0.38) PKMTHRBTRIM24OPRK1PDE4D
SCHEMBL16132461 0.81 CYP11B2 (0.40) PKMBMPR1BBMPR1AACVRL1ACVR1
SCHEMBL29778811 0.81 PKM (0.38) PKMTHRBTRIM24OPRK1PDE4D
SCHEMBL256751 0.77 KMT2A (0.46) THRBOPRK1PDE4DPOLBMEN1
SCHEMBL768709 0.72 JAK2 (0.38) TRIM24ALDH1A1GAA
SCHEMBL24080922 0.72 BRPF1 (0.40) THRBOPRK1PDE4DLMNAMEN1
SCHEMBL2471070 0.71 LMNA (0.35) LMNAHSD17B10MEN1KMT2AMAPT
SCHEMBL31528133 0.70 HTT (0.37) PKMPOLBTP53HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227472-A1 FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227472-A1 FUSED PYRIDONE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF KRAS, NRAS, WEE1 PKM 2019/4885THRB 3148/4885TRIM24 3573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.